KRAS (G12C) mutation‐induced TOPK overexpression contributes to tumour progression in non‐small cell lung cancer

KRAS mutation is the most frequent type of genetic mutation in non‐small cell lung cancer (NSCLC), especially in lung adenocarcinoma. However, KRAS mutation can affect many biological processes and the mechanisms underlying KRAS mutation‐mediate carcinogenesis in NSCLC have not been fully understood...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Chang, Yao, Shuo, Zou, Yanmei, Lu, Hui, Chen, Xiuqiong, Wang, Yali, Zheng, Kun, Zhu, Feng, Wang, Yihua, Xiong, Hua, Zhu, Junfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273069/
https://www.ncbi.nlm.nih.gov/pubmed/37226642
http://dx.doi.org/10.1111/jcmm.17640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273069/
https://www.ncbi.nlm.nih.gov/pubmed/37226642
http://dx.doi.org/10.1111/jcmm.17640

Ejemplares similares